Screener
Acurx Pharmaceuticals, Inc. ACXP Q2 2026 earnings
Reported August 14, 2026 · Before market open
EPS-$0.53Miss by $0.15
EPS estimate-$0.38
Next report
Nov 11, 2026 (in 2 months)EPS estimate-$0.45
Versus estimates
Diluted EPS
FAQ
- When did Acurx Pharmaceuticals, Inc. report Q2 2026 earnings?
- Acurx Pharmaceuticals, Inc. (ACXP) reported Q2 2026 earnings on August 14, 2026 before market open.
- What were Acurx Pharmaceuticals, Inc.'s Q2 2026 revenue and EPS?
- Acurx Pharmaceuticals, Inc. reported eps of $-0.53 for Q2 2026.
- Did Acurx Pharmaceuticals, Inc. beat estimates in Q2 2026?
- EPS missed the consensus estimate of $-0.38 by $0.15.
- How did Acurx Pharmaceuticals, Inc.'s Q2 2026 results compare year-over-year?
- Compared to the same quarter a year prior, eps grew 72.0% from $-1.89.
- Where can I find Acurx Pharmaceuticals, Inc.'s Q2 2026 SEC filings?
- You can read the 10-Q periodic report (0001104659-26-095904) directly on SEC EDGAR. The filing index links above go to sec.gov.
